Genetic Testing in Guiding Treatment for Patients With Brain Metastases
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03994796 |
Recruitment Status :
Recruiting
First Posted : June 21, 2019
Last Update Posted : January 11, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
CDK Gene Mutation Metastatic Malignant Neoplasm in the Brain Metastatic Malignant Solid Neoplasm NTRK Family Gene Mutation PI3K Gene Mutation ROS1 Gene Mutation | Drug: Abemaciclib Drug: PI3K Inhibitor GDC-0084 Drug: Entrectinib | Phase 2 |


PRIMARY OBJECTIVES:
I. To determine the activity of a CDK inhibitor in patients with progressive brain metastases derived from lung cancer, breast cancer, and other cancers harboring actionable genetic alterations associated with sensitivity to CDK inhibitors as measured by response rate (Response Assessment in Neuro-Oncology [RANO] criteria).
II. To determine the activity of a PI3K inhibitor in patients with progressive brain metastases derived from lung cancer, breast cancer, and other cancers harboring actionable genetic alterations in the PI3K pathway as measured by response rate (RANO criteria).
III: To determine the activity of an NTRK/ROS1 inhibitor in patients with progressive brain metastases derived from lung cancer harboring actionable NTRK/ROS1 gene fusions as measured by response rate (RANO criteria).
SECONDARY OBJECTIVES:
I. To evaluate the systemic response by Response Evaluation Criteria in Solid Tumors (RECIST) criteria in each of the cohorts determined by treatment and primary cancer type.
II. To evaluate the clinical benefit rate (complete response [CR] + partial response [PR] + stable disease [SD]) by Brain Metastases (BM)-RANO for central nervous system (CNS) in each of the cohorts determined by treatment and primary cancer type.
III. To evaluate the clinical benefit rate (CR + PR + SD) by RECIST for extracranial disease in each of the cohorts determined by treatment and primary cancer type.
IV. To evaluate the duration of response by BM-RANO in each of the cohorts determined by treatment and primary cancer type.
V. To evaluate the duration of response by RECIST in each of the cohorts determined by treatment and primary cancer type.
VI. To evaluate the progression-free survival for intracranial disease in each of the cohorts determined by treatment and primary cancer type.
VII. To evaluate the progression-free survival for extracranial disease in each of the cohorts determined by treatment and primary cancer type.
VIII. To evaluate the site of first progression (CNS versus [vs] non-CNS) in each of the cohorts determined by treatment and primary cancer type.
IX. To evaluate the overall survival in each of the cohorts determined by treatment and primary cancer type.
X. To evaluate the toxicity profile of agents in patients with brain metastases in each of the cohorts determined by treatment and primary cancer type.
OUTLINE: Patients are assigned to 1 of 3 arms.
ARM I (CDK GENE MUTATION): Patients receive abemaciclib orally (PO) twice daily (BID) on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
ARM II (PI3K GENE MUTATION): Patients receive PI3K inhibitor GDC-0084 PO once daily (QD) on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
ARM III (NTRK/ROS1 GENE MUTATION): Patients receive entrectinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 8 weeks for 2 years, then every 3 months for years 3-4, and then every 6 months thereafter for up to 5 years after registration.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 150 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Genomically-Guided Treatment Trial in Brain Metastases |
Actual Study Start Date : | August 15, 2019 |
Estimated Primary Completion Date : | July 2021 |
Estimated Study Completion Date : | June 2025 |

Arm | Intervention/treatment |
---|---|
Experimental: Arm I (CDK gene mutation)
Patients receive abemaciclib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
|
Drug: Abemaciclib
Given PO |
Experimental: Arm II (PI3K gene mutation)
Patients receive PI3K inhibitor GDC-0084 PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
|
Drug: PI3K Inhibitor GDC-0084
Given PO |
Experimental: Arm III (NTRK/ROS1 gene mutation)
Patients receive entrectinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
|
Drug: Entrectinib
Given PO |
- Objective response rate in the brain [ Time Frame: Up to 5 years ]Assessed per Response Assessment in Neuro-Oncology (RANO) criteria for brain metastases. The response rate is defined as the number of patients who have achieved complete response (CR) or partial response (PR) per RANO for brain metastases criteria during treatment with CDK, PI3K, or NTRK/ROS inhibitors divided by total number of evaluable patients. The response rate and associated exact confidence interval will be estimated within each cohort defined by the targeted agent and histology.
- Systemic response for extracranial disease [ Time Frame: Up to 5 years ]Assessed with Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria. Will be estimated using the systemic response rate (SRR) - where SRR is defined as the number of evaluable patients achieving a response (PR or CR per RECIST 1.1) during treatment with study therapy divided by the total number of evaluable patients. Point estimates will be generated for systemic response rates within each cohort with corresponding 95% binomial confidence intervals.
- Clinical benefit rate for central nervous system (CNS) [ Time Frame: Up to 5 years ]Evaluated by Response Assessment in Neuro-Oncology (RANO) criteria. Will be estimated as the number of evaluable patients achieving stable disease (SD), partial response (PR), or complete response (CR) as their best objective response during treatment with protocol therapy divided by the total number of evaluable patients. Point estimates will be generated for clinical benefit rates within each cohort with corresponding 95% binomial confidence intervals.
- Clinical benefit rate for extracranial disease [ Time Frame: Up to 5 years ]Assessed by Response Evaluation Criteria in Solid Tumors (RECIST). Will be estimated as the number of evaluable patients achieving stable disease (SD), partial response (PR), or complete response (CR) as their best objective response (per RECIST for extracranial disease) during treatment with protocol therapy divided by the total number of evaluable patients. Point estimates will be generated for clinical benefit rates within each cohort with corresponding 95% binomial confidence intervals.
- Duration of response for brain metastases [ Time Frame: From the time measurement criteria are met for CR or PR for brain metastases until the first date that progressive CNS disease or death is documented, assessed up to 5 years ]Duration of response for brain metastases is defined for all evaluable patients who have achieved a confirmed response as the time from the date at which the patient's objective status for brain metastases is first noted to be a CR or PR (per Response Assessment in Neuro-Oncology [RANO] for brain metastases) to the date of the earliest progressive CNS disease is documented or death. The median and 95% confidence intervals will be estimated using the Kaplan-Meier estimator. No formal comparison will be made among the cohorts.
- Duration of response for extracranial disease [ Time Frame: From the time measurement criteria are met for CR or PR for extracranial disease until the first date that progressive disease for extracranial disease or death is documented, assessed up to 5 years ]Duration of response for extracranial disease is defined for all evaluable patients who have achieved a confirmed response as the time from the date at which the patient's objective status for extranial disease is first noted to be a CR or PR (per RECIST1.1) to the date of the earliest progression (PD) for extracranial disease is documented or death. The median and 95% confidence intervals will be estimated using the Kaplan-Meier estimator. No formal comparison will be made among the cohorts.
- Progression-free survival (PFS) - intracranial [ Time Frame: From first day of study treatment to the earliest date documentation of intracranial disease progression or death from any cause, assessed up to 5 years ]Intracranial PFS is defined as the time from the first day of study treatment to the earliest date of intracranial disease progression (per RANO for brain metastases) or death from any cause, whichever comes first. The median and 95% confidence intervals will be estimated using the Kaplan-Meier estimator. No formal comparison will be made among the cohorts.
- Progression-free survival (PFS) - extracranial [ Time Frame: From the first day of study treatment to the earliest date of documentation of extracranial disease progression or death from any cause, assessed up to 5 years ]Extracranial PFS is defined as the time from the first day of study treatment to the earliest date of extracranial disease progression (per RECIST1.1) or death from any cause, whichever comes first. The median and 95% confidence intervals will be estimated using the Kaplan-Meier estimator. No formal comparison will be made among the cohorts.
- Site of first progression [ Time Frame: Up to 24 months ]The site of first progression will be estimated descriptively within each cohort within 12 and 24 months after starting protocol treatment. The first progression is defined as the first documented central nervous system (CNS) progression per Response Assessment in Neuro-Oncology (RANO) or extracranial progression per Response Evaluation Criteria in Solid Tumors (RECIST), whichever occurs first. The percentage of extracranial progression at first progression within 12 and 24 months after starting protocol treatment will be estimated as number of patients who experience the first progression which is extracranial progression divided by number of patients who are still at risk up to 12 and 24 months, respectively.
- Overall survival [ Time Frame: From the first day of study treatment to death due to any cause, assessed up to 5 years ]Overall survival is defined as the time from the first day of study treatment to death due to any cause. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator. No formal comparison will be made among the cohorts.
- Incidence of adverse events [ Time Frame: Up to 5 years ]Assessed per National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, toxicity is defined as adverse events that are classified as possibly, probably, or definitely related to study treatment. Toxicities will be evaluated via the ordinal CTCAE standard toxicity grading. Overall toxicity incidence as well as toxicity profiles by patient and treatment cohort will be explored and summarized. Frequency distributions, graphical techniques and other descriptive measures will form the basis of the analysis. No formal comparison will be made among the cohorts.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
PRE-REGISTRATION ELIGIBILITY CRITERIA (ALL PATIENTS) • Tissue available for biomarker testing (any brain metastasis tissue and extracranial site from any prior resection or biopsy).
REGISTRATION ELIGIBILITY CRITERIA (ALL PATIENTS)
- Participants must have histologically confirmed metastatic disease to the brain from any solid tumor. Note: this includes patients that have controlled extracranial disease with progressive intracranial metastasis, as well as patients that have progressive intracranial and extracranial disease.
-
New or progressive brain metastases are defined as any one of the following:
- Untreated measurable lesions in patients who have received surgery and/or stereotactic radiosurgery (SRS) to one or more other lesions.
- Residual or progressive lesions after surgery if asymptomatic.
- Patients who have had prior whole-brain radiotherapy (WBRT) and/or SRS and then whose lesions have progressed by BM-RANO criteria or there are new lesions, are eligible. Lesions treated with SRS may be eligible if there is unequivocal evidence of progression.
- Patients who have not previously been treated with cranial radiation (e.g. WBRT or SRS) are eligible, but such patients must be asymptomatic or neurologically stable from their CNS metastases.
- Measurable CNS disease (> 10 mm).
- Ability to obtain magnetic resonance imaging (MRI)s.
- No surgery within 2 weeks prior to or after registration.
-
No chemotherapy within 14 days prior to registration (Note: for abemaciclib arm, a 21-day chemotherapy washout is required).
- For melanoma, patients must have progressed after prior immune checkpoint blockade or for BRAF positive melanoma, BRAF/MEK inhibitors.
- For lung cancer, EGFR mutant patients must have failed EGFR therapies
- For HER2-positive breast cancer patients, patients must have received at least one prior HER-2 directed therapy in the metastatic setting.
- For triple negative breast cancer (TNBC), patients must have received at least one chemotherapy in the metastatic setting.
- For estrogen receptor (ER)/progesterone receptor (PR)+ breast cancer, patients must have received at least one endocrine therapy in the metastatic setting.
- Breast cancer patients who have received ribociclib or palbociclib are eligible as long as there is documentation of CDK4 pathway alteration on a biopsy at the point of progression post-ribociclib or palbociclib.
- Tissue available for sequencing (any brain metastasis tissue and extracranial site from any prior resection or biopsy that was resected as part of clinical care). If the patient does not have any evidence of extracranial disease, brain metastasis tissue is sufficient for eligibility.
- Presence of clinically actionable alteration in NTRK, ROS1, or CDK pathway or PI3K pathway in both a brain metastasis and extracranial site.
- Not pregnant and not nursing, because this study involves investigational agents whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown. Therefore, for women of childbearing potential only, a negative pregnancy test done =< 14 days prior to registration is required (Note: for abemaciclib arm, pregnancy test is required =< 7 days prior to registration).
- No known leptomeningeal involvement.
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
- Adequate organ function.
- Absolute neutrophil count (ANC) >= 1,500/mm^3.
- Platelet count >= 100,000/mm^3.
- Total bilirubin =< 1.5 x upper limit of normal (ULN) except in patients with Gilbert's disease.
- Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 x upper limit of normal (ULN).
- Creatinine =< 1.5 mg/dL OR calculated (Calc.) creatinine clearance > 45 mL/min.
- No uncontrolled medical comorbidities per investigator discretion (e.g. interstitial lung disease, severe dyspnea at rest or requiring oxygen therapy, history of major surgical resection involving the stomach or small bowel, or preexisting Crohn's disease or ulcerative colitis or a preexisting chronic condition resulting in baseline Grade 2 or higher diarrhea).
- Concurrent radiation to symptomatic non-target sites within neural axis is allowed (provided there is at least one untreated target lesion).
- Concurrent systemic corticosteroids are allowed if stable dose of dexamethasone for 7 days prior to registration. Baseline doses and changes in steroid dosing will be captured.
- No concurrent administration of anticancer therapies (except for endocrine therapy or continuation of hormonal therapy or trastuzumab in breast cancer patients). No chemotherapy, targeted therapy or immunotherapy within 14 days prior to entering the study (Note: For abemaciclib arm, a 21-day chemotherapy washout is required).
- Chronic concomitant treatment with strong inhibitors of CYP3A4 is not allowed on this study. Patients on strong CYP3A4 inhibitors must discontinue the drug 14 days prior to registration on the study.
- Chronic concomitant treatment with strong CYP3A4 inducers is not allowed. Patients must discontinue the drug 14 days prior to the start of study treatment.
ADDITIONAL REGISTRATION ELIGIBILITY CRITERIA FOR GDC-0084 ARM
- Urine protein to creatinine (UPC) ratio < 1 or urine protein =< 1.
- Recent acute myocardial infarction in the last 6 months or current angina pectoris are excluded. Patients with symptomatic bradycardia should have an electrocardiogram at baseline. If QT interval > 470 msec, the patient is excluded.
- Patients with uncontrolled type I or II diabetes mellitus should be excluded. Uncontrolled diabetes is defined as glycosylated hemoglobin (HbA1c) > 9% in addition to fasting glucose > 140 mg/dL on at least 2 occasions within 14 days prior to registration.
ADDITIONAL REGISTRATION ELIGIBILITY CRITERIA FOR ENTRECTINIB ARM
• Concurrent use of H2 receptor antagonists, receptor antagonists, proton pump inhibitors (PPIs), and/or antacids are prohibited.
ADDITIONAL REGISTRATION ELIGIBILITY CRITERIA FOR ABEMACICLIB ARM
- Hemoglobin >= g/dL. Patients may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator. Initial treatment must not begin earlier than the day after the erythrocyte transfusion.
- Patients who received chemotherapy must have recovered (Common Terminology Criteria for Adverse Events [CTCAE] Grade ≤1) from the acute effects of chemotherapy except for residual alopecia or Grade 2 peripheral neuropathy prior to randomization. A washout period of at least 21 days is required between last chemotherapy dose and registration (provided the patient did not receive radiotherapy).
- Patients who received adjuvant radiotherapy must have completed and fully recovered from the acute effects of radiotherapy. A washout period of at least 14 days is required between end of radiotherapy and registration.
- For females of childbearing potential: A female of childbearing potential, must have a negative serum pregnancy test within 7 days prior to registration and agree to use a highly effective contraception method during the treatment period and for 3 weeks following the last dose of abemaciclib. Contraceptive methods may include an intrauterine device [IUD] or barrier method. If condoms are used as a barrier method, a spermicidal agent should be added as a double barrier protection. Cases of pregnancy that occur during maternal exposures to abemaciclib should be reported. If a patient or spouse/partner is determined to be pregnant following abemaciclib initiation, she must discontinue treatment immediately. Data on fetal outcome and breast-feeding are to be collected for regulatory reporting and drug safety evaluation.
- Patients with active bacterial infection (requiring intravenous [IV] antibiotics at time of initiating study treatment), fungal infection, or detectable viral infection (such as known human immunodeficiency virus positivity or with known active hepatitis B or C [for example, hepatitis B surface antigen positive] are excluded. Screening is not required for enrollment.
- Patients with personal history of any of the following conditions: syncope of cardiovascular etiology, ventricular arrhythmia of pathological origin (including, but not limited to, ventricular tachycardia and ventricular fibrillation), or sudden cardiac arrest, are excluded.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03994796
Contact: Priscilla Brastianos, MD | 617-724-1074 | pbrastianos@partners.org |


United States, Alaska | |
Anchorage Associates in Radiation Medicine | Recruiting |
Anchorage, Alaska, United States, 98508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Radiation Therapy Center | Recruiting |
Anchorage, Alaska, United States, 99504 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Breast Care and Surgery LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Oncology and Hematology LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Women's Cancer Care | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Oncology Centre | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Katmai Oncology Group | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Alaska Medical Center | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Arizona | |
Cancer Center at Saint Joseph's | Recruiting |
Phoenix, Arizona, United States, 85004 | |
Contact: Site Public Contact 602-406-8222 | |
Principal Investigator: Richard L. Deming | |
Mayo Clinic Hospital in Arizona | Recruiting |
Phoenix, Arizona, United States, 85054 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Sani H. Kizilbash | |
Mayo Clinic in Arizona | Recruiting |
Scottsdale, Arizona, United States, 85259 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Sani H. Kizilbash | |
United States, Arkansas | |
Mercy Hospital Fort Smith | Recruiting |
Fort Smith, Arkansas, United States, 72903 | |
Contact: Site Public Contact 800-378-9373 | |
Principal Investigator: Jay W. Carlson | |
CHI Saint Vincent Cancer Center Hot Springs | Recruiting |
Hot Springs, Arkansas, United States, 71913 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, California | |
Mission Hope Medical Oncology - Arroyo Grande | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
Providence Saint Joseph Medical Center/Disney Family Cancer Center | Recruiting |
Burbank, California, United States, 91505 | |
Contact: Site Public Contact 818-847-4793 Najee.Boucher@providence.org | |
Principal Investigator: Alison K. Conlin | |
Epic Care-Dublin | Recruiting |
Dublin, California, United States, 94568 | |
Contact: Site Public Contact 925-875-1677 | |
Principal Investigator: Lisa Bailey | |
Bay Area Breast Surgeons Inc | Recruiting |
Emeryville, California, United States, 94608 | |
Contact: Site Public Contact 510-835-9900 | |
Principal Investigator: Lisa Bailey | |
Epic Care Partners in Cancer Care | Recruiting |
Emeryville, California, United States, 94608 | |
Contact: Site Public Contact 510-629-6682 | |
Principal Investigator: Lisa Bailey | |
UC San Diego Moores Cancer Center | Recruiting |
La Jolla, California, United States, 92093 | |
Contact: Site Public Contact 858-822-5354 cancercto@ucsd.edu | |
Principal Investigator: David E. Piccioni | |
Cedars Sinai Medical Center | Recruiting |
Los Angeles, California, United States, 90048 | |
Contact: Site Public Contact 310-423-8965 | |
Principal Investigator: Jeremy D. Rudnick | |
Contra Costa Regional Medical Center | Recruiting |
Martinez, California, United States, 94553-3156 | |
Contact: Site Public Contact 925-957-5400 | |
Principal Investigator: Lisa Bailey | |
Alta Bates Summit Medical Center - Summit Campus | Recruiting |
Oakland, California, United States, 94609 | |
Contact: Site Public Contact 510-204-1414 | |
Principal Investigator: Lisa Bailey | |
Bay Area Tumor Institute | Recruiting |
Oakland, California, United States, 94609 | |
Contact: Site Public Contact 510-465-2242 lradke@bati.org | |
Principal Investigator: Lisa Bailey | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 877-827-8839 ucstudy@uci.edu | |
Principal Investigator: Daniela A. Bota | |
Sharp Memorial Hospital | Recruiting |
San Diego, California, United States, 92123 | |
Contact: Site Public Contact 858-939-5062 cathy.wood@sharp.com | |
Principal Investigator: Charles H. Redfern | |
Mission Hope Medical Oncology - Santa Maria | Recruiting |
Santa Maria, California, United States, 93444 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
Torrance Memorial Physician Network - Cancer Care | Recruiting |
Torrance, California, United States, 90505 | |
Contact: Site Public Contact 310-750-3300 courtney.steeneken@tmphysicians.com | |
Principal Investigator: Jeremy D. Rudnick | |
Torrance Memorial Medical Center | Recruiting |
Torrance, California, United States, 90509 | |
Contact: Site Public Contact 310-517-4665 | |
Principal Investigator: Jeremy D. Rudnick | |
Epic Care Cyberknife Center | Recruiting |
Walnut Creek, California, United States, 94597 | |
Contact: Site Public Contact 510-465-8016 somega@bati.org | |
Principal Investigator: Lisa Bailey | |
United States, Colorado | |
Penrose-Saint Francis Healthcare | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Penrose | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Porter Adventist Hospital | Recruiting |
Denver, Colorado, United States, 80210 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Southwest Oncology PC | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Anthony Hospital | Recruiting |
Lakewood, Colorado, United States, 80228 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Littleton Adventist Hospital | Recruiting |
Littleton, Colorado, United States, 80122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Longmont United Hospital | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Longmont | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Parker Adventist Hospital | Recruiting |
Parker, Colorado, United States, 80138 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Mary Corwin Medical Center | Recruiting |
Pueblo, Colorado, United States, 81004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Connecticut | |
Smilow Cancer Center/Yale-New Haven Hospital | Recruiting |
New Haven, Connecticut, United States, 06510 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: Antonio M. Omuro | |
Yale University | Recruiting |
New Haven, Connecticut, United States, 06520 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: Antonio M. Omuro | |
United States, Florida | |
Boca Raton Regional Hospital | Recruiting |
Boca Raton, Florida, United States, 33486 | |
Contact: Site Public Contact 561-955-4800 | |
Principal Investigator: Sajeel A. Chowdhary | |
UM Sylvester Comprehensive Cancer Center at Coral Gables | Recruiting |
Coral Gables, Florida, United States, 33146 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Maria del Pilar Guillermo Prieto Eibl | |
UM Sylvester Comprehensive Cancer Center at Deerfield Beach | Recruiting |
Deerfield Beach, Florida, United States, 33442 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Maria del Pilar Guillermo Prieto Eibl | |
Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Site Public Contact 954-267-7750 | |
Principal Investigator: Tareq Al Baghdadi | |
Mayo Clinic in Florida | Recruiting |
Jacksonville, Florida, United States, 32224-9980 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Sani H. Kizilbash | |
University of Miami Miller School of Medicine-Sylvester Cancer Center | Recruiting |
Miami, Florida, United States, 33136 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Maria del Pilar Guillermo Prieto Eibl | |
United States, Georgia | |
Emory University Hospital Midtown | Recruiting |
Atlanta, Georgia, United States, 30308 | |
Contact: Site Public Contact 888-946-7447 | |
Principal Investigator: Jim Zhong | |
Emory University Hospital/Winship Cancer Institute | Recruiting |
Atlanta, Georgia, United States, 30322 | |
Contact: Site Public Contact 404-778-1868 | |
Principal Investigator: Jim Zhong | |
Emory Saint Joseph's Hospital | Recruiting |
Atlanta, Georgia, United States, 30342 | |
Contact: Site Public Contact 404-851-7115 | |
Principal Investigator: Jim Zhong | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Recruiting |
Boise, Idaho, United States, 83706 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Cancer Care Center-Caldwell | Recruiting |
Caldwell, Idaho, United States, 83605 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Medical Center | Recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Walter Knox Memorial Hospital | Recruiting |
Emmett, Idaho, United States, 83617 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Idaho Urologic Institute-Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Kootenai Cancer Center | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Cancer Clinic | Recruiting |
Sandpoint, Idaho, United States, 83864 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
United States, Illinois | |
Rush - Copley Medical Center | Recruiting |
Aurora, Illinois, United States, 60504 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Suparna Mantha | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Priya U. Kumthekar | |
Rush University Medical Center | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-942-5498 clinical_trials@rush.edu | |
Principal Investigator: Joo Yeon Nam | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: Stefania Maraka | |
University of Chicago Comprehensive Cancer Center | Recruiting |
Chicago, Illinois, United States, 60637 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Deric M. Park | |
Carle on Vermilion | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Suparna Mantha | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Suparna Mantha | |
Northwestern Medicine Lake Forest Hospital | Recruiting |
Lake Forest, Illinois, United States, 60045 | |
Contact: Site Public Contact cancertrials@northwestern.edu | |
Principal Investigator: Priya U. Kumthekar | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Suparna Mantha | |
Good Samaritan Regional Health Center | Recruiting |
Mount Vernon, Illinois, United States, 62864 | |
Contact: Site Public Contact 618-242-4600 | |
Principal Investigator: Jay W. Carlson | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Suparna Mantha | |
The Carle Foundation Hospital | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Suparna Mantha | |
Rush-Copley Healthcare Center | Recruiting |
Yorkville, Illinois, United States, 60560 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Suparna Mantha | |
United States, Iowa | |
Mary Greeley Medical Center | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Boone | Recruiting |
Boone, Iowa, United States, 50036 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Mercy Hospital | Recruiting |
Council Bluffs, Iowa, United States, 51503 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Greater Regional Medical Center | Recruiting |
Creston, Iowa, United States, 50801 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Methodist Medical Center | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-6727 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Des Moines | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-282-2921 | |
Principal Investigator: Robert J. Behrens | |
Broadlawns Medical Center | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-282-2200 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Lutheran Hospital | Recruiting |
Des Moines, Iowa, United States, 50316 | |
Contact: Site Public Contact 515-241-8704 | |
Principal Investigator: Robert J. Behrens | |
McFarland Clinic PC-Trinity Cancer Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Trinity Regional Medical Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-574-8302 | |
Principal Investigator: Robert J. Behrens | |
University of Iowa/Holden Comprehensive Cancer Center | Recruiting |
Iowa City, Iowa, United States, 52242 | |
Contact: Site Public Contact 800-237-1225 | |
Principal Investigator: Varun Monga | |
McFarland Clinic PC-Jefferson | Recruiting |
Jefferson, Iowa, United States, 50129 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Marshalltown | Recruiting |
Marshalltown, Iowa, United States, 50158 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Methodist West Hospital | Recruiting |
West Des Moines, Iowa, United States, 50266-7700 | |
Contact: Site Public Contact 515-343-1000 | |
Principal Investigator: Robert J. Behrens | |
Mercy Medical Center-West Lakes | Recruiting |
West Des Moines, Iowa, United States, 50266 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Kentucky | |
Flaget Memorial Hospital | Recruiting |
Bardstown, Kentucky, United States, 40004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Commonwealth Cancer Center-Corbin | Recruiting |
Corbin, Kentucky, United States, 40701 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Radiation Oncology Resource Center | Recruiting |
Lexington, Kentucky, United States, 40504 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Hospital East | Recruiting |
Lexington, Kentucky, United States, 40509 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
University of Kentucky/Markey Cancer Center | Not yet recruiting |
Lexington, Kentucky, United States, 40536 | |
Contact: Site Public Contact 859-257-3379 | |
Principal Investigator: John L. Villano | |
Saint Joseph London | Recruiting |
London, Kentucky, United States, 40741 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saints Mary and Elizabeth Hospital | Recruiting |
Louisville, Kentucky, United States, 40215 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center Northeast | Recruiting |
Louisville, Kentucky, United States, 40245 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center South | Recruiting |
Shepherdsville, Kentucky, United States, 40165 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Louisiana | |
Ochsner LSU Health Monroe Medical Center | Recruiting |
Monroe, Louisiana, United States, 71202 | |
Contact: Site Public Contact 318-813-1404 LPost@lsuhsc.edu | |
Principal Investigator: Gary V. Burton | |
Louisiana State University Health Science Center | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Aaron G. Mammoser | |
University Medical Center New Orleans | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Aaron G. Mammoser | |
LSU Health Sciences Center at Shreveport | Recruiting |
Shreveport, Louisiana, United States, 71103 | |
Contact: Site Public Contact 318-813-1404 LPost@lsuhsc.edu | |
Principal Investigator: Gary V. Burton | |
United States, Massachusetts | |
Massachusetts General Hospital Cancer Center | Recruiting |
Boston, Massachusetts, United States, 02114 | |
Contact: Site Public Contact 877-726-5130 | |
Principal Investigator: Priscilla K. Brastianos | |
Dana-Farber Cancer Institute | Recruiting |
Boston, Massachusetts, United States, 02215 | |
Contact: Site Public Contact 877-442-3324 | |
Principal Investigator: Priscilla K. Brastianos | |
Mercy Medical Center | Suspended |
Springfield, Massachusetts, United States, 01104 | |
United States, Michigan | |
Hickman Cancer Center | Recruiting |
Adrian, Michigan, United States, 49221 | |
Contact: Site Public Contact 517-265-0116 | |
Principal Investigator: Rex B. Mowat | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
University of Michigan Comprehensive Cancer Center | Recruiting |
Ann Arbor, Michigan, United States, 48109 | |
Contact: Site Public Contact 800-865-1125 | |
Principal Investigator: Aki Morikawa | |
Bronson Battle Creek | Recruiting |
Battle Creek, Michigan, United States, 49017 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
IHA Hematology Oncology Consultants-Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Caro Cancer Center | Recruiting |
Caro, Michigan, United States, 48723 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hematology Oncology Consultants-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Newland Medical Associates-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
East China Township, Michigan, United States, 48054 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesee Cancer and Blood Disease Treatment Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesee Hematology Oncology PC | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hurley Medical Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Helen DeVos Children's Hospital at Spectrum Health | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Mercy Health Saint Mary's | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Academic Hematology Oncology Specialists | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Bronson Methodist Hospital | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
West Michigan Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Borgess Medical Center | Recruiting |
Kalamazoo, Michigan, United States, 49048 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hope Cancer Clinic | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Mary Mercy Hospital | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Macomb Township | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Mary's Oncology/Hematology Associates of Marlette | Recruiting |
Marlette, Michigan, United States, 48453 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Toledo Clinic Cancer Centers-Monroe | Recruiting |
Monroe, Michigan, United States, 48162 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
Mercy Health Mercy Campus | Recruiting |
Muskegon, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Lakeland Hospital Niles | Recruiting |
Niles, Michigan, United States, 49120 | |
Contact: Site Public Contact 616-391-1230 | |
Principal Investigator: Kathleen J. Yost | |
Cancer and Hematology Centers of Western Michigan - Norton Shores | Recruiting |
Norton Shores, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 connie.szczepanek@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Ascension Providence Hospitals - Novi | Recruiting |
Novi, Michigan, United States, 48374 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Adam M. Forman | |
21st Century Oncology-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Hope Cancer Center | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Newland Medical Associates-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Spectrum Health Reed City Hospital | Recruiting |
Reed City, Michigan, United States, 49677 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Great Lakes Cancer Management Specialists-Rochester Hills | Recruiting |
Rochester Hills, Michigan, United States, 48309 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Oncology Hematology Associates of Saginaw Valley PC | Recruiting |
Saginaw, Michigan, United States, 48604 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Lakeland Medical Center Saint Joseph | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Marie Yeager Cancer Center | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Ascension Providence Hospitals - Southfield | Recruiting |
Southfield, Michigan, United States, 48075 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Adam M. Forman | |
Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
Sterling Heights, Michigan, United States, 48312 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Ascension Saint Joseph Hospital | Recruiting |
Tawas City, Michigan, United States, 48764 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Munson Medical Center | Recruiting |
Traverse City, Michigan, United States, 49684 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Advanced Breast Care Center PLLC | Recruiting |
Warren, Michigan, United States, 48088 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Macomb Hematology Oncology PC | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Michigan Breast Specialists-Warren | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Saint Mary's Oncology/Hematology Associates of West Branch | Recruiting |
West Branch, Michigan, United States, 48661 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Metro Health Hospital | Recruiting |
Wyoming, Michigan, United States, 49519 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Huron Gastroenterology PC | Recruiting |
Ypsilanti, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
Ypsilanti, Michigan, United States, 48197 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
United States, Minnesota | |
Fairview Ridges Hospital | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology - Burnsville | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Cambridge Medical Center | Recruiting |
Cambridge, Minnesota, United States, 55008 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Fairview Southdale Hospital | Recruiting |
Edina, Minnesota, United States, 55435 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Fairview Clinics and Surgery Center Maple Grove | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology Hematology PA-Maplewood | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Saint John's Hospital - Healtheast | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Health Partners Inc | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Monticello Cancer Center | Recruiting |
Monticello, Minnesota, United States, 55362 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
New Ulm Medical Center | Recruiting |
New Ulm, Minnesota, United States, 56073 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Fairview Northland Medical Center | Recruiting |
Princeton, Minnesota, United States, 55371 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
North Memorial Medical Health Center | Recruiting |
Robbinsdale, Minnesota, United States, 55422 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Mayo Clinic in Rochester | Recruiting |
Rochester, Minnesota, United States, 55905 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Sani H. Kizilbash | |
Coborn Cancer Center at Saint Cloud Hospital | Active, not recruiting |
Saint Cloud, Minnesota, United States, 56303 | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Saint Francis Regional Medical Center | Recruiting |
Shakopee, Minnesota, United States, 55379 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Lakeview Hospital | Recruiting |
Stillwater, Minnesota, United States, 55082 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Ridgeview Medical Center | Recruiting |
Waconia, Minnesota, United States, 55387 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Rice Memorial Hospital | Recruiting |
Willmar, Minnesota, United States, 56201 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Minnesota Oncology Hematology PA-Woodbury | Recruiting |
Woodbury, Minnesota, United States, 55125 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Fairview Lakes Medical Center | Recruiting |
Wyoming, Minnesota, United States, 55092 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
United States, Mississippi | |
University of Mississippi Medical Center | Recruiting |
Jackson, Mississippi, United States, 39216 | |
Contact: Site Public Contact 601-815-6700 | |
Principal Investigator: Nawal Shaikh | |
United States, Missouri | |
Saint Louis Cancer and Breast Institute-Ballwin | Recruiting |
Ballwin, Missouri, United States, 63011 | |
Contact: Site Public Contact 314-251-7058 | |
Principal Investigator: Jay W. Carlson | |
Cox Cancer Center Branson | Suspended |
Branson, Missouri, United States, 65616 | |
University of Missouri - Ellis Fischel | Recruiting |
Columbia, Missouri, United States, 65212 | |
Contact: Site Public Contact 573-882-7440 | |
Principal Investigator: Tolga Tuncer | |
Siteman Cancer Center at West County Hospital | Active, not recruiting |
Creve Coeur, Missouri, United States, 63141 | |
Freeman Health System | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-347-4030 LJCrockett@freemanhealth.com | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Joplin | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-556-3074 esmeralda.carrillo@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Delbert Day Cancer Institute at PCRMC | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-8776 kaysmith@phelpshealth.org | |
Principal Investigator: Jay W. Carlson | |
Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-6379 | |
Principal Investigator: Jay W. Carlson | |
Heartland Regional Medical Center | Recruiting |
Saint Joseph, Missouri, United States, 64506 | |
Contact: Site Public Contact 816-271-7937 linda.schumacher@mymlc.com | |
Principal Investigator: Jay W. Carlson | |
Saint Louis Cancer and Breast Institute-South City | Recruiting |
Saint Louis, Missouri, United States, 63109 | |
Contact: Site Public Contact 314-353-1870 | |
Principal Investigator: Jay W. Carlson | |
Washington University School of Medicine | Active, not recruiting |
Saint Louis, Missouri, United States, 63110 | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact janet.lesko@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center-South County | Active, not recruiting |
Saint Louis, Missouri, United States, 63129 | |
Siteman Cancer Center at Christian Hospital | Active, not recruiting |
Saint Louis, Missouri, United States, 63136 | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center at Saint Peters Hospital | Active, not recruiting |
Saint Peters, Missouri, United States, 63376 | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
CoxHealth South Hospital | Recruiting |
Springfield, Missouri, United States, 65807 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Washington | Recruiting |
Washington, Missouri, United States, 63090 | |
Contact: Site Public Contact 636-390-1600 | |
Principal Investigator: Jay W. Carlson | |
United States, Montana | |
Community Hospital of Anaconda | Recruiting |
Anaconda, Montana, United States, 59711 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Benefis Healthcare- Sletten Cancer Institute | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Great Falls Clinic | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kalispell Regional Medical Center | Recruiting |
Kalispell, Montana, United States, 59901 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Patrick Hospital - Community Hospital | Recruiting |
Missoula, Montana, United States, 59802 | |
Contact: Site Public Contact 406-327-3118 amy.hanneman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Community Medical Hospital | Recruiting |
Missoula, Montana, United States, 59804 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
CHI Health Saint Francis | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
CHI Health Good Samaritan | Recruiting |
Kearney, Nebraska, United States, 68847 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Elizabeth Regional Medical Center | Recruiting |
Lincoln, Nebraska, United States, 68510 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Immanuel Medical Center | Recruiting |
Omaha, Nebraska, United States, 68122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Bergan Mercy Medical Center | Recruiting |
Omaha, Nebraska, United States, 68124 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Lakeside Hospital | Recruiting |
Omaha, Nebraska, United States, 68130 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Creighton University Medical Center | Recruiting |
Omaha, Nebraska, United States, 68131 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Midlands Community Hospital | Recruiting |
Papillion, Nebraska, United States, 68046 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, New Hampshire | |
Dartmouth Hitchcock Medical Center | Recruiting |
Lebanon, New Hampshire, United States, 03756 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@dartmouth.edu | |
Principal Investigator: Gary N. Schwartz | |
United States, New Jersey | |
Morristown Medical Center | Recruiting |
Morristown, New Jersey, United States, 07960 | |
Contact: Site Public Contact 973-971-5900 | |
Principal Investigator: Robert D. Aiken | |
Capital Health Medical Center-Hopewell | Recruiting |
Pennington, New Jersey, United States, 08534 | |
Contact: Site Public Contact 800-255-3440 | |
Principal Investigator: Neel Gandhi | |
Overlook Hospital | Recruiting |
Summit, New Jersey, United States, 07902 | |
Contact: Site Public Contact 908-522-2043 | |
Principal Investigator: Robert D. Aiken | |
United States, New Mexico | |
Lovelace Medical Center-Saint Joseph Square | Recruiting |
Albuquerque, New Mexico, United States, 87102 | |
Contact: Site Public Contact 505-272-0530 AYost@nmcca.org | |
Principal Investigator: Atul Kumar | |
University of New Mexico Cancer Center | Recruiting |
Albuquerque, New Mexico, United States, 87102 | |
Contact: Site Public Contact 505-925-0366 LByatt@nmcca.org | |
Principal Investigator: Atul Kumar | |
Lovelace Radiation Oncology | Recruiting |
Albuquerque, New Mexico, United States, 87109 | |
Contact: Site Public Contact 505-272-0530 AYost@nmcca.org | |
Principal Investigator: Atul Kumar | |
United States, New York | |
Arnot Ogden Medical Center/Falck Cancer Center | Active, not recruiting |
Elmira, New York, United States, 14905 | |
Glens Falls Hospital | Recruiting |
Glens Falls, New York, United States, 12801 | |
Contact: Site Public Contact 518-926-6700 | |
Principal Investigator: Alissa A. Thomas | |
Laura and Isaac Perlmutter Cancer Center at NYU Langone | Recruiting |
New York, New York, United States, 10016 | |
Contact: Site Public Contact 212-263-4434 prmc.coordinator@nyumc.org | |
Principal Investigator: Christine Cordova | |
NYP/Weill Cornell Medical Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-746-1848 | |
Principal Investigator: Rajiv S. Magge | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
State University of New York Upstate Medical University | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Site Public Contact 315-464-5476 | |
Principal Investigator: Mijung Lee | |
United States, North Carolina | |
UNC Lineberger Comprehensive Cancer Center | Recruiting |
Chapel Hill, North Carolina, United States, 27599 | |
Contact: Site Public Contact 877-668-0683 cancerclinicaltrials@med.unc.edu | |
Principal Investigator: Simon Khagi | |
Carolinas Medical Center/Levine Cancer Institute | Recruiting |
Charlotte, North Carolina, United States, 28203 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Ashley L. Sumrall | |
Atrium Health Pineville/LCI-Pineville | Recruiting |
Charlotte, North Carolina, United States, 28210 | |
Contact: Site Public Contact 980-442-2000 | |
Principal Investigator: Ashley L. Sumrall | |
Atrium Health Cabarrus/LCI-Concord | Recruiting |
Concord, North Carolina, United States, 28025 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Ashley L. Sumrall | |
Duke University Medical Center | Recruiting |
Durham, North Carolina, United States, 27710 | |
Contact: Site Public Contact 888-275-3853 | |
Principal Investigator: Jeffrey Crawford | |
Margaret R Pardee Memorial Hospital | Recruiting |
Hendersonville, North Carolina, United States, 28791 | |
Contact: Site Public Contact 828-696-4716 karen.morris@unchealth.unc.edu | |
Principal Investigator: Lynn J. Howie | |
Vidant Oncology-Kenansville | Recruiting |
Kenansville, North Carolina, United States, 28349 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Vidant Oncology-Kinston | Recruiting |
Kinston, North Carolina, United States, 28501 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Vidant Oncology-Richlands | Recruiting |
Richlands, North Carolina, United States, 28574 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
United States, Ohio | |
UHHS-Chagrin Highlands Medical Center | Recruiting |
Beachwood, Ohio, United States, 44122 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Robin A. Buerki | |
Good Samaritan Hospital - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45220 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Bethesda North Hospital | Recruiting |
Cincinnati, Ohio, United States, 45242 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Westside | Recruiting |
Cincinnati, Ohio, United States, 45247 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Anderson | Recruiting |
Cincinnati, Ohio, United States, 45255 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Case Western Reserve University | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Robin A. Buerki | |
Ohio State University Comprehensive Cancer Center | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu | |
Principal Investigator: Shirley S. Ong | |
UH Seidman Cancer Center at Lake Health Mentor Campus | Suspended |
Mentor, Ohio, United States, 44060 | |
Mercy Health Perrysburg Cancer Center | Suspended |
Perrysburg, Ohio, United States, 43551 | |
Mercy Health - Saint Anne Hospital | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Rex B. Mowat | |
Toledo Clinic Cancer Centers-Toledo | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Sarah Sung | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
United States, Oregon | |
Saint Alphonsus Medical Center-Baker City | Recruiting |
Baker City, Oregon, United States, 97814 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Charles Health System | Recruiting |
Bend, Oregon, United States, 97701 | |
Contact: Site Public Contact 541-706-2909 nosall@stcharleshealthcare.org | |
Principal Investigator: Alison K. Conlin | |
Clackamas Radiation Oncology Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Bay Area Hospital | Recruiting |
Coos Bay, Oregon, United States, 97420 | |
Contact: Site Public Contact 541-269-8392 cherie.cox@bayareahospital.org | |
Principal Investigator: Alison K. Conlin | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Ontario | Recruiting |
Ontario, Oregon, United States, 97914 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Charles Health System-Redmond | Recruiting |
Redmond, Oregon, United States, 97756 | |
Contact: Site Public Contact 541-706-2909 | |
Principal Investigator: Alison K. Conlin | |
United States, Pennsylvania | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Lehigh Valley Hospital - Muhlenberg | Recruiting |
Bethlehem, Pennsylvania, United States, 18017 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Pocono Medical Center | Recruiting |
East Stroudsburg, Pennsylvania, United States, 18301 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Lehigh Valley Hospital-Hazleton | Recruiting |
Hazleton, Pennsylvania, United States, 18201 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Tareq Al Baghdadi | |
Thomas Jefferson University Hospital | Recruiting |
Philadelphia, Pennsylvania, United States, 19107 | |
Contact: Site Public Contact 215-955-6084 | |
Principal Investigator: Nina L. Martinez | |
UPMC-Magee Womens Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15213 | |
Contact: Site Public Contact 412-647-2811 | |
Principal Investigator: Adam M. Brufsky | |
University of Pittsburgh Cancer Institute (UPCI) | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-647-8073 | |
Principal Investigator: Adam M. Brufsky | |
United States, Texas | |
Saint Joseph Regional Cancer Center | Recruiting |
Bryan, Texas, United States, 77802 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Parkland Memorial Hospital | Active, not recruiting |
Dallas, Texas, United States, 75235 | |
UT Southwestern/Simmons Cancer Center-Dallas | Active, not recruiting |
Dallas, Texas, United States, 75390 | |
UT Southwestern/Simmons Cancer Center-Fort Worth | Active, not recruiting |
Fort Worth, Texas, United States, 76104 | |
M D Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 877-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Barbara J. O'Brien | |
Memorial Hermann Texas Medical Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 713-792-3245 | |
Principal Investigator: Ankush Bhatia | |
Memorial Hermann Northeast Hospital | Recruiting |
Humble, Texas, United States, 77338 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Ankush Bhatia | |
Memorial Hermann The Woodlands Hospital | Recruiting |
The Woodlands, Texas, United States, 77380 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Ankush Bhatia | |
United States, Utah | |
Huntsman Cancer Institute/University of Utah | Recruiting |
Salt Lake City, Utah, United States, 84112 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Howard Colman | |
United States, Vermont | |
Central Vermont Medical Center/National Life Cancer Treatment | Recruiting |
Berlin, Vermont, United States, 05602 | |
Contact: Site Public Contact 802-225-5400 | |
Principal Investigator: Alissa A. Thomas | |
University of Vermont Medical Center | Recruiting |
Burlington, Vermont, United States, 05401 | |
Contact: Site Public Contact 802-656-4101 rpo@uvm.edu | |
Principal Investigator: Alissa A. Thomas | |
University of Vermont and State Agricultural College | Recruiting |
Burlington, Vermont, United States, 05405 | |
Contact: Site Public Contact 802-656-8990 rpo@uvm.edu | |
Principal Investigator: Alissa A. Thomas | |
United States, Virginia | |
Inova Schar Cancer Institute | Recruiting |
Fairfax, Virginia, United States, 22031 | |
Contact: Site Public Contact 703-720-5210 Stephanie.VanBebber@inova.org | |
Principal Investigator: Kathleen K. Harnden | |
Inova Fair Oaks Hospital | Recruiting |
Fairfax, Virginia, United States, 22033 | |
Contact: Site Public Contact 703-720-5210 Stephanie.VanBebber@inova.org | |
Principal Investigator: Kathleen K. Harnden | |
United States, Washington | |
Providence Regional Cancer System-Aberdeen | Recruiting |
Aberdeen, Washington, United States, 98520 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth Saint Joseph Medical Center | Recruiting |
Bellingham, Washington, United States, 98225 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Harrison HealthPartners Hematology and Oncology-Bremerton | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Harrison Medical Center | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Highline Medical Center-Main Campus | Recruiting |
Burien, Washington, United States, 98166 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer System-Centralia | Recruiting |
Centralia, Washington, United States, 98531 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Cancer Institute-Edmonds | Recruiting |
Edmonds, Washington, United States, 98026 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Saint Elizabeth Hospital | Recruiting |
Enumclaw, Washington, United States, 98022 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer Partnership | Recruiting |
Everett, Washington, United States, 98201 | |
Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Francis Hospital | Recruiting |
Federal Way, Washington, United States, 98003 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Swedish Cancer Institute-Issaquah | Recruiting |
Issaquah, Washington, United States, 98029 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Kadlec Clinic Hematology and Oncology | Recruiting |
Kennewick, Washington, United States, 99336 | |
Contact: Site Public Contact 509-783-4637 research@kadlecmed.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Lacey | Recruiting |
Lacey, Washington, United States, 98503 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Clare Hospital | Recruiting |
Lakewood, Washington, United States, 98499 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Saint John Medical Center | Recruiting |
Longview, Washington, United States, 98632 | |
Contact: Site Public Contact 360-514-2016 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Harrison HealthPartners Hematology and Oncology-Poulsbo | Recruiting |
Poulsbo, Washington, United States, 98370 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Pacific Gynecology Specialists | Recruiting |
Seattle, Washington, United States, 98104 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Ballard Campus | Recruiting |
Seattle, Washington, United States, 98107 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122-4307 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Cherry Hill | Recruiting |
Seattle, Washington, United States, 98122-5711 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth United General Medical Center | Recruiting |
Sedro-Woolley, Washington, United States, 98284 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Shelton | Recruiting |
Shelton, Washington, United States, 98584 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Franciscan Research Center-Northwest Medical Plaza | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Southwest Medical Center | Recruiting |
Vancouver, Washington, United States, 98664 | |
Contact: Site Public Contact 360-514-3940 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Mary Regional Cancer Center | Recruiting |
Walla Walla, Washington, United States, 99362 | |
Contact: Site Public Contact 509-897-5993 Cheryl.Dodd@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Yelm | Recruiting |
Yelm, Washington, United States, 98597 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Wisconsin | |
Aurora Cancer Care-Southern Lakes VLCC | Recruiting |
Burlington, Wisconsin, United States, 53105 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Health Care Germantown Health Center | Recruiting |
Germantown, Wisconsin, United States, 53022 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Cancer Care-Grafton | Recruiting |
Grafton, Wisconsin, United States, 53024 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora BayCare Medical Center | Recruiting |
Green Bay, Wisconsin, United States, 54311 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Cancer Care-Kenosha South | Recruiting |
Kenosha, Wisconsin, United States, 53142 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Bay Area Medical Group-Marinette | Recruiting |
Marinette, Wisconsin, United States, 54143 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Cancer Care-Milwaukee | Recruiting |
Milwaukee, Wisconsin, United States, 53209 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Saint Luke's Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53215 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Medical College of Wisconsin | Recruiting |
Milwaukee, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-805-3666 | |
Principal Investigator: Fernando Santos Pinheiro | |
Aurora Sinai Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53233 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Cancer Center of Western Wisconsin | Recruiting |
New Richmond, Wisconsin, United States, 54017 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Daniel M. Anderson | |
Vince Lombardi Cancer Clinic - Oshkosh | Recruiting |
Oshkosh, Wisconsin, United States, 54904 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Cancer Care-Racine | Recruiting |
Racine, Wisconsin, United States, 53406 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Vince Lombardi Cancer Clinic-Sheboygan | Recruiting |
Sheboygan, Wisconsin, United States, 53081 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Medical Center in Summit | Recruiting |
Summit, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Vince Lombardi Cancer Clinic-Two Rivers | Recruiting |
Two Rivers, Wisconsin, United States, 54241 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora Cancer Care-Milwaukee West | Recruiting |
Wauwatosa, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
Aurora West Allis Medical Center | Recruiting |
West Allis, Wisconsin, United States, 53227 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Michael A. Thompson | |
United States, Wyoming | |
Billings Clinic-Cody | Recruiting |
Cody, Wyoming, United States, 82414 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Welch Cancer Center | Recruiting |
Sheridan, Wyoming, United States, 82801 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp |
Study Chair: | Priscilla Brastianos, MD | Massachusetts General Hospital |
Responsible Party: | Alliance for Clinical Trials in Oncology |
ClinicalTrials.gov Identifier: | NCT03994796 |
Other Study ID Numbers: |
A071701 NCI-2019-00744 ( Registry Identifier: NCI Clinical Trial Reporting Program ) U10CA180821 ( U.S. NIH Grant/Contract ) |
First Posted: | June 21, 2019 Key Record Dates |
Last Update Posted: | January 11, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Neoplasms Entrectinib Protein Kinase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |